Cochrane · systematic review · CD006744
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men
Fisher, E, Subramonian, K, Omar, MI · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
IncontinenceAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
3
No studies
3
Included studies
NR
No studies 3 · 50%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 16.7%Moderate 2 · 33.3%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Alpha blocker versus placebo or control for acute urinary retention in adult men
Population: acute urinary retention in adult men
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Ability to void spontaneously after TWOC without the need for re‐catheterisation Alpha blocker vs placebo or control | RR 1.55 [1.36, 1.76] | 9 studies · 1044 participants | Moderate Downgraded: risk of bias, imprecision, publication bias |
Incidence of recurrent urinary retention Alpha blocker vs placebo or control | RR 0.69 [0.6, 0.79] | 8 studies · 1023 participants | Moderate Downgraded: risk of bias, imprecision, publication bias |
Need for prostatic surgery ‐ not reported Alpha blocker vs placebo or control | no estimate extracted | NR | No studies |
Condition‐specific QoL ‐ not reported Alpha blocker vs placebo or control | no estimate extracted | NR | No studies |
Cost effectiveness ‐ not reported Alpha blocker vs placebo or control | no estimate extracted | NR | No studies |
Number with adverse effects Alpha blocker vs placebo or control | RR 1.2 [0.74, 1.95] | 4 studies · 657 participants | Low Downgraded: publication bias |